Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Theoria Science, a Japan-based cancer diagnostics and treatment developer commercialising research from Tokyo Medical University, has received an undisclosed amount of series A funding from SBI Investment, the venture capital arm of financial services firms SBI Holdings. The company advances research by its chief science officer, Takahiro Ochiya, a professor at the Institute of Medical Science at Tokyo Medical University.
University of Maryland School of Medicine has launched US-based spinout Vitruvian Bio to develop RNA-based diagnostics for Covid-19 that…
